Trials / Completed
CompletedNCT00567177
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Accepted
Summary
We propose to investigate the response to Restasis, over a prolonged period of time in heavy computer users with dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Restasis, Refresh Plus | Restasis 0.4ml- (in the eye) Instill one drop twice daily in morning and evening Refresh Plus 0.4ml- (in the eye) Instill one drop twice daily in morning and evening |
Timeline
- Start date
- 2007-11-01
- Completion
- 2008-04-01
- First posted
- 2007-12-04
- Last updated
- 2010-07-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00567177. Inclusion in this directory is not an endorsement.